{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:20:27Z","timestamp":1788481227341,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["2022\/46\/E\/NZ3\/00144"],"award-info":[{"award-number":["2022\/46\/E\/NZ3\/00144"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02640-y","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:54:25Z","timestamp":1769583265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The mTORC2 component SIN1 post-transcriptionally regulates TYMS levels and modulates P53 activity in response to 5-FU chemotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Abdulrahman El","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Zakrzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladyslava","family":"Liudkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remigiusz","family":"Serwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhalim","family":"Azzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2640_CR1","doi-asserted-by":"publisher","unstructured":"Chu E, Allegra CJ, 1993. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Adv Exp Med Biol 339, 143\u2013151; discussion 165\u2013167. https:\/\/doi.org\/10.1007\/978-1-4615-2488-5_16","DOI":"10.1007\/978-1-4615-2488-5_16"},{"key":"2640_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1146\/annurev.bi.64.070195.003445","volume":"64","author":"CW Carreras","year":"1995","unstructured":"Carreras CW, Santi DV. The catalytic mechanism and structure of thymidylate synthase. Annu Rev Biochem. 1995;64:721\u201362. https:\/\/doi.org\/10.1146\/annurev.bi.64.070195.003445.","journal-title":"Annu Rev Biochem"},{"key":"2640_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3892\/ol.2010.227","volume":"2","author":"M Kimura","year":"2011","unstructured":"Kimura M, Kuwabara Y, Mitsui A, Ishiguro H, Sugito N, Tanaka T, et al. Thymidylate synthetase and dihydropyrimidine dehydrogenase mRNA levels in esophageal cancer. Oncol Lett. 2011;2:297\u2013301. https:\/\/doi.org\/10.3892\/ol.2010.227.","journal-title":"Oncol Lett"},{"key":"2640_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11060-006-9191-4","volume":"80","author":"JM Grunda","year":"2006","unstructured":"Grunda JM, Nabors LB, Palmer CA, Chhieng DC, Steg A, Mikkelsen T, et al. Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM). J Neurooncol. 2006;80:261\u201374. https:\/\/doi.org\/10.1007\/s11060-006-9191-4.","journal-title":"J Neurooncol"},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.ymthe.2024.06.014","volume":"32","author":"R Sartori-Maldonado","year":"2024","unstructured":"Sartori-Maldonado R, Montaser H, Soppa I, Eurola S, Juutila J, Balaz M, et al. Thymidylate synthase disruption to limit cell proliferation in cell therapies. Mol Ther. 2024;32:2535\u201348. https:\/\/doi.org\/10.1016\/j.ymthe.2024.06.014.","journal-title":"Mol Ther"},{"key":"2640_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s1535-6108(04)00080-7","volume":"5","author":"L Rahman","year":"2004","unstructured":"Rahman L, Voeller D, Rahman M, Lipkowitz S, Allegra C, Barrett JC, et al. Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. Cancer Cell. 2004;5:341\u201351. https:\/\/doi.org\/10.1016\/s1535-6108(04)00080-7.","journal-title":"Cancer Cell"},{"key":"2640_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330\u20138. https:\/\/doi.org\/10.1038\/nrc1074.","journal-title":"Nat Rev Cancer"},{"key":"2640_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/s0925-4439(02)00082-0","volume":"1587","author":"GJ Peters","year":"2002","unstructured":"Peters GJ, Backus HHJ, Freemantle S, van Triest B, Codacci-Pisanelli G, van der Wilt CL, et al. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta. 2002;1587:194\u2013205. https:\/\/doi.org\/10.1016\/s0925-4439(02)00082-0.","journal-title":"Biochim Biophys Acta"},{"key":"2640_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/s0925-4439(02)00080-7","volume":"1587","author":"J Liu","year":"2002","unstructured":"Liu J, Schmitz JC, Lin X, Tai N, Yan W, Farrell M, et al. Thymidylate synthase as a translational regulator of cellular gene expression. Biochim Biophys Acta. 2002;1587:174\u201382. https:\/\/doi.org\/10.1016\/s0925-4439(02)00080-7.","journal-title":"Biochim Biophys Acta"},{"key":"2640_CR10","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.1073\/pnas.88.20.8977","volume":"88","author":"E Chu","year":"1991","unstructured":"Chu E, Koeller DM, Casey JL, Drake JC, Chabner BA, Elwood PC, et al. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci U S A. 1991;88:8977\u201381. https:\/\/doi.org\/10.1073\/pnas.88.20.8977.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2640_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/bies.950180306","volume":"18","author":"E Chu","year":"1996","unstructured":"Chu E, Allegra CJ. The role of thymidylate synthase as an RNA binding protein. BioEssays. 1996;18:191\u20138. https:\/\/doi.org\/10.1002\/bies.950180306.","journal-title":"BioEssays"},{"key":"2640_CR12","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1073\/pnas.96.7.3769","volume":"96","author":"J Ju","year":"1999","unstructured":"Ju J, Pedersen-Lane J, Maley F, Chu E. Regulation of p53 expression by thymidylate synthase. Proc Natl Acad Sci U S A. 1999;96:3769\u201374. https:\/\/doi.org\/10.1073\/pnas.96.7.3769.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2640_CR13","doi-asserted-by":"publisher","first-page":"e1464","DOI":"10.1002\/ctm2.1464","volume":"13","author":"E Ezine","year":"2023","unstructured":"Ezine E, Lebbe C, Dumaz N. Unmasking the tumourigenic role of SIN1\/MAPKAP1 in the mTOR complex 2. Clin Transl Med. 2023;13:e1464. https:\/\/doi.org\/10.1002\/ctm2.1464.","journal-title":"Clin Transl Med"},{"key":"2640_CR14","doi-asserted-by":"publisher","first-page":"120072","DOI":"10.1016\/j.lfs.2021.120072","volume":"286","author":"N Klinhom-On","year":"2021","unstructured":"Klinhom-On N, Seubwai W, Sawanyawisuth K, Obchoei S, Mahalapbutr P, Wongkham S. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. Life Sci. 2021;286:120072. https:\/\/doi.org\/10.1016\/j.lfs.2021.120072.","journal-title":"Life Sci"},{"key":"2640_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","volume":"1263","author":"MY Pai","year":"2015","unstructured":"Pai MY, Lomenick B, Hwang H, Schiestl R, McBride W, Loo JA, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol. 2015;1263:287\u201398. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_22.","journal-title":"Methods Mol Biol"},{"key":"2640_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1083\/jcb.201210077","volume":"199","author":"AL Goldberg","year":"2012","unstructured":"Goldberg AL. Development of proteasome inhibitors as research tools and cancer drugs. J Cell Biol. 2012;199:583\u20138. https:\/\/doi.org\/10.1083\/jcb.201210077.","journal-title":"J Cell Biol"},{"key":"2640_CR17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","volume":"11","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11:1437\u20138. https:\/\/doi.org\/10.1080\/15548627.2015.1066957.","journal-title":"Autophagy"},{"key":"2640_CR18","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1038\/s41467-023-39063-7","volume":"14","author":"BJ Ignacio","year":"2023","unstructured":"Ignacio BJ, Dijkstra J, Mora N, Slot EFJ, van Weijsten MJ, Storkebaum E, et al. THRONCAT: metabolic labeling of newly synthesized proteins using a bioorthogonal threonine analog. Nat Commun. 2023;14:3367. https:\/\/doi.org\/10.1038\/s41467-023-39063-7.","journal-title":"Nat Commun"},{"key":"2640_CR19","doi-asserted-by":"publisher","first-page":"114803","DOI":"10.1016\/j.celrep.2024.114803","volume":"43","author":"TM St\u0119pkowski","year":"2024","unstructured":"St\u0119pkowski TM, Linke V, Stadnik D, Zakrzewski M, Zawada AE, Serwa RA, et al. Temporal alterations of the nascent proteome in response to mitochondrial stress. Cell Rep. 2024;43:114803. https:\/\/doi.org\/10.1016\/j.celrep.2024.114803.","journal-title":"Cell Rep"},{"key":"2640_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"2640_CR21","doi-asserted-by":"publisher","first-page":"121320","DOI":"10.1016\/j.lfs.2022.121320","volume":"315","author":"SM El-Daly","year":"2023","unstructured":"El-Daly SM, Abo-Elfadl MT, Hussein J, Abo-Zeid MAM. Enhancement of the antitumor effect of 5-fluorouracil with modulation in drug transporters expression using PI3K inhibitors in colorectal cancer cells. Life Sci. 2023;315:121320. https:\/\/doi.org\/10.1016\/j.lfs.2022.121320.","journal-title":"Life Sci"},{"key":"2640_CR22","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/s41598-017-02548-9","volume":"7","author":"K Ishida","year":"2017","unstructured":"Ishida K, Ito C, Ohmori Y, Kume K, Sato KA, Koizumi Y, et al. Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil. Sci Rep. 2017;7:2262. https:\/\/doi.org\/10.1038\/s41598-017-02548-9.","journal-title":"Sci Rep"},{"key":"2640_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004.","journal-title":"Cell"},{"key":"2640_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov DD, Ali SM, Sengupta S, Sheen J-H, Hsu PP, Bagley AF, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell. 2006;22:159\u201368. https:\/\/doi.org\/10.1016\/j.molcel.2006.03.029.","journal-title":"Mol Cell"},{"key":"2640_CR25","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1021\/acs.jproteome.9b00500","volume":"18","author":"M Gaetani","year":"2019","unstructured":"Gaetani M, Sabatier P, Saei AA, Beusch CM, Yang Z, Lundstr\u00f6m SL, et al. Proteome integral solubility alteration: a high-throughput proteomics assay for target deconvolution. J Proteome Res. 2019;18:4027\u201337. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00500.","journal-title":"J Proteome Res"},{"key":"2640_CR26","doi-asserted-by":"publisher","first-page":"11040","DOI":"10.1038\/ncomms11040","volume":"7","author":"H Almqvist","year":"2016","unstructured":"Almqvist H, Axelsson H, Jafari R, Dan C, Mateus A, Haraldsson M, et al. CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil. Nat Commun. 2016;7:11040. https:\/\/doi.org\/10.1038\/ncomms11040.","journal-title":"Nat Commun"},{"key":"2640_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.chembiol.2021.06.007","volume":"29","author":"YY Liang","year":"2022","unstructured":"Liang YY, Bacanu S, Sreekumar L, Ramos AD, Dai L, Michaelis M, et al. CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity. Cell Chem Biol. 2022;29:572-585.e8. https:\/\/doi.org\/10.1016\/j.chembiol.2021.06.007.","journal-title":"Cell Chem Biol"},{"key":"2640_CR28","doi-asserted-by":"publisher","first-page":"e0135017","DOI":"10.1371\/journal.pone.0135017","volume":"10","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Pan B, Sun H, Chen G, Su B, Huang Y. Characterization of Sin1 isoforms reveals an mTOR-dependent and independent function of Sin1\u03b3. PLoS ONE. 2015;10:e0135017. https:\/\/doi.org\/10.1371\/journal.pone.0135017.","journal-title":"PLoS ONE"},{"key":"2640_CR29","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","volume":"16","author":"MA Frias","year":"2006","unstructured":"Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA, et al. mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol. 2006;16:1865\u201370. https:\/\/doi.org\/10.1016\/j.cub.2006.08.001.","journal-title":"Curr Biol"},{"key":"2640_CR30","doi-asserted-by":"publisher","first-page":"eabh2290","DOI":"10.1126\/scisignal.abh2290","volume":"15","author":"L Liu","year":"2022","unstructured":"Liu L, Dai X, Yin S, Liu P, Hill EG, Wei W, et al. DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway. Sci Signal. 2022;15:eabh2290. https:\/\/doi.org\/10.1126\/scisignal.abh2290.","journal-title":"Sci Signal"},{"key":"2640_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","volume":"25","author":"PAJ Muller","year":"2014","unstructured":"Muller PAJ, Vousden KH. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell. 2014;25:304\u201317. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.021.","journal-title":"Cancer Cell"},{"key":"2640_CR32","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41556-022-00949-1","volume":"24","author":"M Chen","year":"2022","unstructured":"Chen M, Choi S, Wen T, Chen C, Thapa N, Lee JH, et al. A p53-phosphoinositide signalosome regulates nuclear AKT activation. Nat Cell Biol. 2022;24:1099\u2013113. https:\/\/doi.org\/10.1038\/s41556-022-00949-1.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2640_CR33","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/emboj\/cdg189","volume":"22","author":"ML Coleman","year":"2003","unstructured":"Coleman ML, Marshall CJ, Olson MF. Ras Promotes P21(Waf1\/Cip1) Protein Stability via a Cyclin D1-Imposed Block in Proteasome-Mediated Degradation. EMBO J. 2003;22(9):2036\u201346. https:\/\/doi.org\/10.1093\/emboj\/cdg189.","journal-title":"EMBO J"},{"key":"2640_CR34","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41598-018-38017-0","volume":"9","author":"V Varghese","year":"2019","unstructured":"Varghese V, Magnani L, Harada-Shoji N, Mauri F, Szydlo RM, Yao S, et al. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. Sci Rep. 2019;9:1505. https:\/\/doi.org\/10.1038\/s41598-018-38017-0.","journal-title":"Sci Rep"},{"key":"2640_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41419-018-1235-0","volume":"9","author":"K Intuyod","year":"2018","unstructured":"Intuyod K, Saavedra-Garc\u00eda P, Zona S, Lai C-F, Jiramongkol Y, Vaeteewoottacharn K, et al. FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance. Cell Death Dis. 2018;9:1185. https:\/\/doi.org\/10.1038\/s41419-018-1235-0.","journal-title":"Cell Death Dis"},{"key":"2640_CR36","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1038\/emboj.2010.271","volume":"29","author":"WJ Oh","year":"2010","unstructured":"Oh WJ, Wu C, Kim SJ, Facchinetti V, Julien L-A, Finlan M, et al. MTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 2010;29:3939\u201351. https:\/\/doi.org\/10.1038\/emboj.2010.271.","journal-title":"EMBO J"},{"key":"2640_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2011.02.014","volume":"144","author":"V Zinzalla","year":"2011","unstructured":"Zinzalla V, Stracka D, Oppliger W, Hall MN. Activation of mTORC2 by association with the ribosome. Cell. 2011;144:757\u201368. https:\/\/doi.org\/10.1016\/j.cell.2011.02.014.","journal-title":"Cell"},{"key":"2640_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.20517\/cdr.2022.136","volume":"6","author":"WH Gmeiner","year":"2023","unstructured":"Gmeiner WH, Okechukwu CC. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. Cancer Drug Resist. 2023;6:257\u201372. https:\/\/doi.org\/10.20517\/cdr.2022.136.","journal-title":"Cancer Drug Resist"},{"key":"2640_CR39","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cell.2018.03.053","volume":"173","author":"I Becher","year":"2018","unstructured":"Becher I, Andr\u00e9s-Pons A, Romanov N, Stein F, Schramm M, Baudin F, et al. Pervasive protein thermal stability variation during the cell cycle. Cell. 2018;173:1495-1507.e18. https:\/\/doi.org\/10.1016\/j.cell.2018.03.053.","journal-title":"Cell"},{"key":"2640_CR40","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41592-019-0499-3","volume":"16","author":"JX Huang","year":"2019","unstructured":"Huang JX, Lee G, Cavanaugh KE, Chang JW, Gardel ML, Moellering RE. High throughput discovery of functional protein modifications by hotspot thermal profiling. Nat Methods. 2019;16:894\u2013901. https:\/\/doi.org\/10.1038\/s41592-019-0499-3.","journal-title":"Nat Methods"},{"key":"2640_CR41","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ncb2860","volume":"15","author":"P Liu","year":"2013","unstructured":"Liu P, Gan W, Inuzuka H, Lazorchak AS, Gao D, Arojo O, et al. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol. 2013;15:1340\u201350. https:\/\/doi.org\/10.1038\/ncb2860.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"2640_CR42","doi-asserted-by":"publisher","first-page":"101778","DOI":"10.1016\/j.xcrm.2024.101778","volume":"5","author":"J-K Chen","year":"2024","unstructured":"Chen J-K, Merrick KA, Kong YW, et al. An RNA damage response network mediates the lethality of 5-FU in colorectal cancer. Cell Rep Med. 2024;5(10):101778. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101778.","journal-title":"Cell Rep Med"},{"key":"2640_CR43","doi-asserted-by":"publisher","first-page":"12534","DOI":"10.1093\/nar\/gkae849","volume":"52","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Naeli P, Onar O, Simms N, Garzia A, Hackett A, et al. Ribosome quality control mitigates the cytotoxicity of ribosome collisions induced by 5-Fluorouracil. Nucleic Acids Res. 2024;52:12534\u201348. https:\/\/doi.org\/10.1093\/nar\/gkae849.","journal-title":"Nucleic Acids Res"},{"key":"2640_CR44","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367\u201372. https:\/\/doi.org\/10.1038\/nbt.1511.","journal-title":"Nat Biotechnol"},{"key":"2640_CR45","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"UniProt Consortium","year":"2025","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609\u201317. https:\/\/doi.org\/10.1093\/nar\/gkae1010.","journal-title":"Nucleic Acids Res"},{"key":"2640_CR46","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10:1794\u2013805. https:\/\/doi.org\/10.1021\/pr101065j.","journal-title":"J Proteome Res"},{"key":"2640_CR47","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731\u201340. https:\/\/doi.org\/10.1038\/nmeth.3901.","journal-title":"Nat Methods"},{"key":"2640_CR48","doi-asserted-by":"publisher","unstructured":"- Cie\u015bla, Maciej, Phuong Cao Thi Ngoc, Eugenia Cordero, et al. \u201cOncogenic Translation Directs Spliceosome Dynamics Revealing an Integral Role for SF3A3 in Breast Cancer.\u201d Molecular Cell. 2021;81(7):1453-1468.e12. https:\/\/doi.org\/10.1016\/j.molcel.2021.01.034.","DOI":"10.1016\/j.molcel.2021.01.034"},{"issue":"5","key":"2640_CR49","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2018.03.008","volume":"173","author":"N Guzzi","year":"2018","unstructured":"Guzzi N, Cie\u015bla M, Cao Thi Ngoc P, et al. Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell. 2018;173(5):1204-1216.e26. https:\/\/doi.org\/10.1016\/j.cell.2018.03.008.","journal-title":"Cell"},{"key":"2640_CR50","doi-asserted-by":"crossref","unstructured":"- Sagliocco, F. A., P. A. Moore, and A. J. Brown. \u201cPolysome Analysis.\u201d Methods in Molecular Biology (Clifton, N.J.) 53 (1996): 297\u2013311. https:\/\/doi.org\/10.1385\/0-89603-319-8:297.","DOI":"10.1385\/0-89603-319-8:297"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02640-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02640-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02640-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:19:17Z","timestamp":1770887957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02640-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02640-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}